Adverse geriatric outcomes secondary to polypharmacy in a mouse model: the influence of aging

A Huizer-Pajkos, AE Kane, SE Howlett… - … Series A: Biomedical …, 2016 - academic.oup.com
We aimed to develop a mouse model of polypharmacy, primarily to establish whether short-
term exposure to polypharmacy causes adverse geriatric outcomes. We also investigated …

Polypharmacy results in functional impairment in mice: novel insights into age and sex interactions

H Wu, J Mach, G Gemikonakli, T Tran… - The Journals of …, 2021 - academic.oup.com
Males and females may respond differently to medications, yet knowledge about sexual
dimorphisms in the effects of polypharmacy remains limited, particularly in aging. This study …

Chronic polypharmacy with increasing drug burden index exacerbates frailty and impairs physical function, with effects attenuated by deprescribing, in aged mice

J Mach, G Gemikonakli, C Logan… - The Journals of …, 2021 - academic.oup.com
Polypharmacy (use of≥ 5 medications) and increasing Drug Burden Index (DBI) score
(measure of person's total exposure to anticholinergic/sedative medications) are associated …

[HTML][HTML] Chronic polypharmacy impairs explorative behavior and reduces synaptic functions in young adult mice

F Eroli, K Johnell, ML Leal, C Adamo, S Hilmer… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
A major challenge in the health care system is the lack of knowledge about the possible
harmful effects of multiple drug treatments in old age. The present study aims to characterize …

Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES)

C Gómez, S Vega-Quiroga, F Bermejo-Pareja… - Gerontology, 2015 - karger.com
Background: Little information is available on the potential association between
polypharmacy and risk of mortality. Objective: To determine in a population-based study …

Comparing effects of polypharmacy on inflammatory profiles in older adults and mice: implications for translational aging research

H Wu, J Mach, D Gnjidic, V Naganathan… - The Journals of …, 2022 - academic.oup.com
Aging and multimorbidity are associated with inflammation. Polypharmacy is common in
older people with multimorbidity. Given the potential for interactions between polypharmacy …

Polypharmacy, physical and nutritional status, and depression in the elderly: do polypharmacy deserve some credits in these problems?

S Eyigor, YG Kutsal, F Toraman, B Durmus… - Experimental aging …, 2021 - Taylor & Francis
Background: To investigate the association of polypharmacy with physical function,
nutritional status, and depression in the elderly. Method: The study included 675 people …

Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study

DV Espino, OV Bazaldua, RF Palmer… - The Journals of …, 2006 - academic.oup.com
Background. Numerous methods have been used to evaluate medication management
quality in older adults; however, their predictive validities are unknown. Major medication …

[HTML][HTML] Geriatric cognitive decline and polypharmacy

V Chippa, K Roy - 2021 - europepmc.org
Geriatric Cognitive Decline and Polypharmacy - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

Clinical pharmacology and the risks of polypharmacy in the geriatric patient

JL Pesante-Pinto - Physical Medicine and Rehabilitation Clinics, 2017 - pmr.theclinics.com
The World Health Organization estimates that worldwide, the proportion of older people in
the total population is increasing at more than 3 times the overall population growth rate …